Invitrogen™ Toripalimab Humanized Recombinant Human Monoclonal Antibody

Human Recombinant Monoclonal Antibody

Supplier:  Invitrogen™ MA542224

Catalog No. PIMA542224

Description

Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.

Toripalimab is a humanized monoclonal antibody that targets programmed death receptor 1 (PD-1). It is used to treat patients with unresectable or metastatic melanoma who have previously failed systemic therapy. It is intended for treatment Breast cancer, lymphoma, malignant melanoma, genitourinary system cancer and other types of solid tumors.

Specifications

• Antigen: Toripalimab Humanized
• Classification: Recombinant Monoclonal
• Conjugate: Unconjugated
• Gene Alias: Loqtorzi; Toripalimab
• Immunogen: Human PDCD1/PD1/CD279.
• Quantity: 100 μg
• Primary or Secondary: Primary
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid
• Target Molecule: Chemical

• Applications: ELISA, SDS-Page
• Concentration: 1.6 mg/mL
• Formulation: PBS with no preservative; pH 7.4
• Host Species: Human
• Purification Method: Protein A
• Regulatory Status: RUO
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG4 κ

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov